Interferon(IFN)-based therapy for hepatitis C virus(HCV)infection has recently been replaced by IFNfree direct-acting antiviral(DAA)-based therapy,which has bee
AIM To understand the effects of delivery mode on the immune cells frequency and function in cord blood and placenta.METHODS We evaluated immunological differen
Worldwide,more than one million people die each year from hepatitis C virus(HCV)related diseases,and over 300 million people are chronically infected with hepa